Publications
Our eBook on the “Brazilian Regulatory Framework for Rare Diseases” is an essential guide to Brazil’s healthcare system, providing a comprehensive analysis of the regulatory processes related to rare disease medications, including gene and cell therapies.
New regulation promises to move the markets of means of payment and exchange.
Has the STJ's decision in REsp 1.991.103/MT finally equalized the principle of company preservation and the rights of extrajudicial creditors after the stay period?
STJ puts an end to controversy over the taxable event.
Brazilian legislation on the taxation of investments abroad will undergo major changes if Bill 4.173/23 is approved in its entirety. These changes could impact the way Brazilian investors and companies operate and invest in assets outside the country.
Businesses have up to 180 days to comply with the new rules. To understand what changes, download our exclusive publication on the topic and stay updated with the latest guidelines in the healthcare sector.
Page 44 of 241
